Xiaowen Wang is an Associate Principal Scientist at Merck, specializing in biomedical science with a focus on molecular and cell biology in the pharmaceutical field. They earned a PhD in Cellular and Molecular Pharmacology from Rutgers University and have significant experience in cancer research, including roles as a Postdoctoral Fellow and Senior Scientist at Merck. Xiaowen has established multiple CRISPR protocols and transgenic models during their tenure, contributing to four peer-reviewed publications and serving as an ad-hoc reviewer for numerous scientific journals. Prior to their current position, they held roles at Sundia MediTech Co., Ltd. and the Cancer Institute of New Jersey, where they developed advanced metabolic assays and managed transgenic mouse colonies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices